The final vancomycin PBPK model applies elimination by glomerular filtration and adequately describes the pharmacokinetics of vancomycin in adults receiving SD, MD of vancomycin ranging from 500mg to 1000mg intravenously. 

This model could be applied for the investigation of drug-drug interactions (DDI), and translation to special populations such as pediatrics with regard GFR based elimination.

